FDA Approval

LUNGevity Foundation Applauds FDA Approval of Zykadia™ (ceritinib) as Additional Tool in Arsenal for Locally Advanced or Metastatic Non-Small Cell Lung Cancer

LUNGevity Foundation Applauds FDA Approval of Zykadia™ (ceritinib) as Additional Tool in Arsenal for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Ceritinib (brand name Zykadia™) will be used for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib (brand name Xalkori™) PR Newswire WASHINGTON, May 1, 2014 WASHINGTON , May 1, 2014 /PRNewswire-USNewswire/ — LUNGevity Foundation applauds the FDA approval of Zykadia™ for the subset of anaplastic lymphoma kinase-positive (ALK+) patients with advanced cases of non-small cell lung cancer who have progressed on or are intolerant to crizotinib. Zykadia™ was given breakthrough therapy designation in March 2013 and received FDA approval under the agency’s accelerated approval program. Having a range of ALK inhibitors provides important options for these patients […]

Stock Analysts

OncoGenex Posts Wider Loss, Beats Revenues

OncoGenex Pharmaceuticals, Inc. ( OGXI ) reported a loss of 59 cents per share in the first quarter of 2014, wider than the Zacks Consensus Estimate of a loss of 44 cents and the year-ago loss of 46 cents per share. First quarter 2014 revenues were $11.7 million, up 131.1% from the year-ago quarter. […]

Stock Analysts

LinkedIn Beats Revenues but Lowers Guidance

LinkedIn ( LNKD ), the largest network of professionals online, reported Q1 earnings after the bell Thursday, beating on both the top and bottom lines for the quarter. Revenues of $473 million in the quarter beat the Zacks consensus estimate of $466 million, representing a 46% gain year over year. […]

Mergers & Acquisitions

Systemax Signs Definitive Agreement to Acquire Netherlands Business-to-Business IT Supplier

Systemax Signs Definitive Agreement to Acquire Netherlands Business-to-Business IT Supplier PR Newswire PORT WASHINGTON, N.Y., May 1, 2014 PORT WASHINGTON, N.Y. , May 1, 2014 /PRNewswire/ — Systemax Inc. (NYSE: SYX) today announced it has signed a definitive agreement to acquire SCC Services B.V., a supplier of business-to-business IT products and services with operations in the Netherlands , subject to certain closing conditions, including approval by the Netherlands Authority for Consumers and Markets […]

Mergers & Acquisitions

BrokerLink acquires Anthony Clark Insurance Brokers Ltd

BrokerLink acquires Anthony Clark Insurance Brokers Ltd Canada NewsWire CALGARY, May 1, 2014 CALGARY , May 1, 2014 /CNW/ – BrokerLink, one of Canada’s largest property and casualty insurance brokerages, announced today the acquisition of the ownership position held by Anthony Clark International Insurance Brokers Ltd in Anthony Clark Insurance Brokers Ltd (ACI). “ACI is a natural fit with BrokerLink. Their existing personal insurance and group programs compliment our own,” said Chris Miller , Head of Alberta Region at BrokerLink […]

Stock Analysts

Embraer SA Beats on Q1 Earnings

Embraer SA’ s ( ERJ ) first-quarter 2014 earnings of 34 cents per American Depository Shares (ADS) spiked 78.9% from 19 cents per ADS in the prior-year quarter. The reported figure also beat the Zacks Consensus Estimate of 22 cents by 54.5%. […]

Stock Analysts

Equity Residential Q1 FFO In Line

Equity Residential ’s ( EQR ) normalized funds from operations (FFO) per share in first-quarter 2014 reached 71 cents, in line with the Zacks Consensus Estimate and within the company’s guided range of 68 cents – 72 cents. Results, however, came 7 cents above the prior-year quarter figure. Quarterly results at this apartment real estate investment trust (REIT) were primarily driven by higher same store net operating income (NOI) and NOI from non-same store properties currently in lease up as well as reduced total interest expense. […]

Stock Analysts

CRL for The Medicines Co.’s Cangrelor

The FDA issued a Complete Response Letter (CRL) to The Medicines Company ’s ( MDCO ) New Drug Application (NDA) for cangrelor. The company is looking to get cangrelor approved for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients suffering from coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) and in patients requiring bridging from oral antiplatelet therapy to surgery. The FDA stated that cangrelor cannot be approved at present […]

Stock Analysts

Lazard Earnings Beat Ests, Revs Up

Driven by top-line growth, Lazard Ltd. ’s ( LAZ ) first-quarter 2014 adjusted earnings came in at 61 cents per share, easily beating the Zacks Consensus Estimate of 55 cents. Moreover, this compares favorably with 28 cents earned in the prior-year quarter. […]

Stock Analysts

Avanir Wins Lawsuit, Shares Up

Shares of Avanir Pharmaceuticals, Inc. ( AVNR ) soared 45.6% after the company announced that the U.S. District Court for the District of Delaware has ruled the patent infringement lawsuit against Par Pharmaceuticals, Inc. […]

Day Trading Radio

Market Radar for May 2nd (Jobs Day)

[youtube 34kZ_mOFtVQ] Today to me was a very bullish day, Event though we ended flat it was expected in front of a major economic report due out tomorrow. Still looking for new highs and tomorrow could be that catalyst. […]

Mergers & Acquisitions

Search Minerals provides corporate update & update on proposed acquisition of MSFA

Search Minerals provides corporate update & update on proposed acquisition of MSFA PR Newswire TORONTO, May 1, 2014 TORONTO , May 1, 2014 /PRNewswire/ – Search Minerals Inc. (“Search” or the “Company”) (TSXV: SMY) is pleased to provide a corporate update on the Company’s activities during the first quarter of 2014 and on the proposed acquisition by the Company of Mineração São Francisco de Assis Ltda. (” MSFA “). […]